https://www.eejournals.org Open Access
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited
Page | 49
donor contributions support long-term, locally driven health improvements [21]. This integrated approach
ultimately fosters greater health equity and regional cooperation.
CONCLUSION
This review highlights the complex interplay between multilateral and bilateral international organizations in
shaping HIV/AIDS policy development in East Africa. Multilateral institutions such as UNAIDS, WHO, and the
Global Fund play a crucial role in promoting coordinated, country-led strategies that emphasize equity,
sustainability, and regional collaboration. Conversely, bilateral donors like PEPFAR and DFID offer targeted
funding and flexibility, often reflecting donor priorities that can sometimes diverge from national agendas. While
both approaches have contributed significantly to expanding access to HIV/AIDS treatment and prevention, their
coexistence has occasionally resulted in fragmented policies, duplication of efforts, and challenges in harmonization.
Strengthening mutual accountability frameworks, promoting country ownership through integrated national health
strategies, and leveraging regional bodies like the East African Community for policy coherence are key to
overcoming these challenges. Future success depends on better alignment and coordination between multilateral
and bilateral efforts, ensuring that funding and technical assistance reinforce national priorities rather than compete
with them. Ultimately, fostering inclusive, transparent partnerships will enhance the effectiveness, sustainability,
and impact of HIV/AIDS interventions in East Africa, supporting resilient health systems capable of responding to
evolving public health needs.
REFERENCES
1. Sia, D., Onadja, Y., Hajizadeh, M., Heymann, S.J., Brewer, T.F., Nandi, A.: What explains gender
inequalities in HIV/AIDS prevalence in sub-Saharan Africa? Evidence from the demographic and health
surveys. BMC Public Health. 16, 1136 (2016). https://doi.org/10.1186/s12889-016-3783-5
2. Obeagu, E. I., Aja, P. M., Okon, M. B., Uti, D. E. Reducing HIV Infection Rate in Women: A Catalyst to
reducing HIV Infection pervasiveness in Africa. International Journal of Innovative and Applied Research.
2023; 11(10):01-06. DOI: 10.58538/IJIAR/2048
3. Adepoju A. O, Amusa M. O, Samson A.O. (2023). Inclusion of nutritional counseling and mental health
services in HIV/AIDS management A paradigm shift Medicine (Baltimore). 2023;102(41):e35673.
http://dx.doi.org/10.1097/MD.0000000000035673
4. HopeSr., K.R.: Africa’s HIV/AIDS Crisis in a Development Context. International Relations. 15, 15–36
(2001). https://doi.org/10.1177/004711701015006003
5. HIV/AIDS | WHO | Regional Office for Africa, https://www.afro.who.int/health-topics/hivaids
6. Madu, C.V., Aloh, H.E., Egba, S.I., et al. The price of progress: Assessing the financial costs of HIV/AIDS
management in East Africa. Medicine (Baltimore). 2025 May 2;104(18):e42300. doi:
10.1097/MD.0000000000042300. PMID: 40324279; PMCID: PMC12055164.
7. Doble, A., Sheridan, Z., Razavi, A., Wilson, A., Okereke, E.: The role of international support programmes
in global health security capacity building: A scoping review. PLOS Glob Public Health. 3, e0001763
(2023). https://doi.org/10.1371/journal.pgph.0001763
8. Chang, M.: Bilateral and Multilateral Mechanisms in Comparison: An Examination Through China’s
Climate Policy. Presented at the January 28 (2022)
9. Alum, E.U., Uti, D.E., Ugwu, O.P.C., Alum, B.N. Toward a cure - Advancing HIV/AIDs treatment
modalities beyond antiretroviral therapy: A Review. Medicine (Baltimore). 2024 Jul 5;103(27):e38768. doi:
10.1097/MD.0000000000038768. PMID: 38968496
10. Agwu E, Ihongbe J. C, Ezeonwumelu J. O, Moazzam M, Lodhi M. M(2015). Baseline burden and
antimicrobial susceptibility of pathogenic bacteria recovered from oral lesions of patients with HIV/AIDS
in South-Western Uganda. Oral Science International, 12, (2), 59-66. https://doi.org/10.1016/S1348-
8643(15)00018-X.
11. Brown, G.W., Rhodes, N., Tacheva, B., Loewenson, R., Shahid, M., Poitier, F.: Challenges in international
health financing and implications for the new pandemic fund. Globalization and Health. 19, 97 (2023).
https://doi.org/10.1186/s12992-023-00999-6
12. Morse, J.C., Keohane, R.O.: Contested multilateralism. The Review of International Organizations. 9, 385–
412 (2014). https://doi.org/10.1007/s11558-014-9188-2
13. Ihongbe J C, Moazzam M I, Pazos V, Agwu E (2015). Non-target oral bacterial resistance to
Cotrimoxazole in HIV/AIDS patients living in South Western Uganda. Spec. Bact. Pathog. J, 1, (1), 01-
08.
14. Elendu, C., Amaechi, D.C., Elendu, T.C., Amaechi, E.C., Elendu, I.D., Akpa, K. N., et al.: Shaping
sustainable paths for HIV/AIDS funding: a review and reminder. Ann Med Surg (Lond). 87, 1415–1445
(2025). https://doi.org/10.1097/MS9.0000000000002976